Exosomes Offer Huge Potential for Cancer Diagnostics

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Exosome Diagnostics and Therapeutics: Global Markets” report to their offering.

The global market for exosome diagnostics and therapeutics is projected to grow from $16.1 million in 2016 to $111.8 million in 2021, a five-year compound annual growth rate (CAGR) of 47.3%. Diagnostics is the largest sector of the market, expected to grow from $10.0 million in 2016 to $100.0 million in 2021 at a CAGR of 58.5% for the period.

Therapeutics is expected to grow from $5.0 million in 2016 to $10.0 million in 2021, a CAGR of 14.9%.

This report provides an overview of the current state of the exosome industry, existing products on the market and detailed analysis of the competitive environments, including new potential markets for novel products, diagnostics and therapeutics development. Forecast provided for the period 2016-2021.

Use this report to:

• Gain insight into the current state of the exosome industry and existing products on the market.
• Analyze competitive environments, including new potential markets for novel products, diagnostics and therapeutics development.
• Learn about significant players in the exosome industry, trends, obstacles, and other information effecting exosome market development.
• Identify the main positive and negative factors within each sector.

Source – BusinessWire